[HTML][HTML] Nanocarriers for ocular drug delivery: Current status and translational opportunity

S Gorantla, VK Rapalli, T Waghule, PP Singh… - RSC …, 2020 - pubs.rsc.org
Ocular diseases have a significant effect on vision and quality of life. Drug delivery to ocular
tissues is a challenge to formulation scientists. The major barriers to delivering drugs to the …

[引用][C] Nanocarriers for ocular drug delivery: current status and translational opportunity

S Gorantla, VK Rapalli, T Waghule, PP Singh… - RSC Advances, 2020 - cir.nii.ac.jp
Nanocarriers for ocular drug delivery: current status and translational opportunity | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …

[PDF][PDF] Nanocarriers for ocular drug delivery: current status and translational opportunity

S Gorantla, VK Rapalli, T Waghule, PP Singh… - scholar.archive.org
Ocular diseases have a significant effect on vision and quality of life. Drug delivery to ocular
tissues is a challenge to formulation scientists. The major barriers to delivering drugs to the …

[引用][C] Nanocarriers for ocular drug delivery: current status and translational opportunity

S Gorantla, VK Rapalli, T Waghule, PP Singh… - RSC …, 2020 - ui.adsabs.harvard.edu
Nanocarriers for ocular drug delivery: current status and translational opportunity - NASA/ADS
Now on home page ads icon ads Enable full ADS view NASA/ADS Nanocarriers for ocular …

Nanocarriers for ocular drug delivery: current status and translational opportunity.

S Gorantla, VK Rapalli, T Waghule, PP Singh… - RSC …, 2020 - europepmc.org
Ocular diseases have a significant effect on vision and quality of life. Drug delivery to ocular
tissues is a challenge to formulation scientists. The major barriers to delivering drugs to the …

[PDF][PDF] Nanocarriers for ocular drug delivery: current status and translational opportunity

S Gorantla, VK Rapalli, T Waghule, PP Singh… - pdfs.semanticscholar.org
Ocular diseases have a significant effect on vision and quality of life. Drug delivery to ocular
tissues is a challenge to formulation scientists. The major barriers to delivering drugs to the …

[HTML][HTML] Nanocarriers for ocular drug delivery: current status and translational opportunity

S Gorantla, VK Rapalli, T Waghule, PP Singh… - RSC …, 2020 - ncbi.nlm.nih.gov
Ocular diseases have a significant effect on vision and quality of life. Drug delivery to ocular
tissues is a challenge to formulation scientists. The major barriers to delivering drugs to the …

Nanocarriers for ocular drug delivery: current status and translational opportunity

S Gorantla, VK Rapalli, T Waghule… - RSC …, 2020 - pubmed.ncbi.nlm.nih.gov
Ocular diseases have a significant effect on vision and quality of life. Drug delivery to ocular
tissues is a challenge to formulation scientists. The major barriers to delivering drugs to the …

Nanocarriers for ocular drug delivery: current status and translational opportunity

S Gorantla, VK Rapalli, T Waghule… - RSC …, 2020 - pubmed.ncbi.nlm.nih.gov
Ocular diseases have a significant effect on vision and quality of life. Drug delivery to ocular
tissues is a challenge to formulation scientists. The major barriers to delivering drugs to the …

[PDF][PDF] Nanocarriers for ocular drug delivery: current status and translational opportunity

S Gorantla, VK Rapalli, T Waghule, PP Singh… - pdfs.semanticscholar.org
Ocular diseases have a significant effect on vision and quality of life. Drug delivery to ocular
tissues is a challenge to formulation scientists. The major barriers to delivering drugs to the …